Degarelix
Back to searchMolecule Structure
Scientific Name
Degarelix
Description of the Drug
Degarelix is a GnRH receptor antagonist used in the management of advanced prostate cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06699
http://www.drugbank.ca/drugs/DB06699
Brand Name(s)
Firmagon
Company Owner(s)
Ferring Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1397034 | ||
| DrugBank | DB06699 | ||
| PubChem: Thomson Pharma | 14890845 | 14939869 | |
| PubChem | 16136245 | 101755083 | |
| Nikkaji | J1.951.873F | ||
| BindingDB | 50102450 | ||
| DrugCentral | 4379 | ||
| ChemicalBook | CB52448443 | ||
| Guide to Pharmacology | 5585 | ||
| rxnorm | FIRMAGON | DEGARELIX | DEGARELIX ACETATE |
| ChEBI | 135961 |
